These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
434 related articles for article (PubMed ID: 32452356)
1. Fluoxetine to improve functional outcomes in patients after acute stroke: the FOCUS RCT. Dennis M; Forbes J; Graham C; Hackett M; Hankey GJ; House A; Lewis S; Lundström E; Sandercock P; Mead G Health Technol Assess; 2020 May; 24(22):1-94. PubMed ID: 32452356 [TBL] [Abstract][Full Text] [Related]
2. Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial. FOCUS Trial Collaboration Lancet; 2019 Jan; 393(10168):265-274. PubMed ID: 30528472 [TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
4. The FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: a study protocol for three multicentre randomised controlled trials. Mead G; Hackett ML; Lundström E; Murray V; Hankey GJ; Dennis M Trials; 2015 Aug; 16():369. PubMed ID: 26289352 [TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of fluoxetine on functional recovery after acute stroke (EFFECTS): a randomised, double-blind, placebo-controlled trial. EFFECTS Trial Collaboration Lancet Neurol; 2020 Aug; 19(8):661-669. PubMed ID: 32702335 [TBL] [Abstract][Full Text] [Related]
6. Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT. Duffy L; Clarke CS; Lewis G; Marston L; Freemantle N; Gilbody S; Hunter R; Kendrick T; Kessler D; King M; Lanham P; Mangin D; Moore M; Nazareth I; Wiles N; Bacon F; Bird M; Brabyn S; Burns A; Donkor Y; Hunt A; Pervin J; Lewis G Health Technol Assess; 2021 Nov; 25(69):1-62. PubMed ID: 34842135 [TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial. AFFINITY Trial Collaboration Lancet Neurol; 2020 Aug; 19(8):651-660. PubMed ID: 32702334 [TBL] [Abstract][Full Text] [Related]
8. The FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: statistical and health economic analysis plan for the trials and for the individual patient data meta-analysis. Graham C; Lewis S; Forbes J; Mead G; Hackett ML; Hankey GJ; Gommans J; Nguyen HT; Lundström E; Isaksson E; Näsman P; Rudberg AS; Dennis M Trials; 2017 Dec; 18(1):627. PubMed ID: 29282099 [TBL] [Abstract][Full Text] [Related]
9. Twelve-Month Outcomes of the AFFINITY Trial of Fluoxetine for Functional Recovery After Acute Stroke: AFFINITY Trial Steering Committee on Behalf of the AFFINITY Trial Collaboration. Hankey GJ; Hackett ML; Almeida OP; Flicker L; Mead GE; Dennis MS; Etherton-Beer C; Ford AH; Billot L; Jan S; Lung T; Lundström E; Sunnerhagen KS; Anderson CS; Thang-Nguyen H; Gommans J; Yi Q; Stroke; 2021 Aug; 52(8):2502-2509. PubMed ID: 34015940 [TBL] [Abstract][Full Text] [Related]
10. Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT. Sprigg N; Flaherty K; Appleton JP; Al-Shahi Salman R; Bereczki D; Beridze M; Ciccone A; Collins R; Dineen RA; Duley L; Egea-Guerrero JJ; England TJ; Karlinski M; Krishnan K; Laska AC; Law ZK; Ovesen C; Ozturk S; Pocock SJ; Roberts I; Robinson TG; Roffe C; Peters N; Scutt P; Thanabalan J; Werring D; Whynes D; Woodhouse L; Bath PM Health Technol Assess; 2019 Jul; 23(35):1-48. PubMed ID: 31322116 [TBL] [Abstract][Full Text] [Related]
11. Behavioural activation therapy for post-stroke depression: the BEADS feasibility RCT. Thomas SA; Drummond AE; Lincoln NB; Palmer RL; das Nair R; Latimer NR; Hackney GL; Mandefield L; Walters SJ; Hatton RD; Cooper CL; Chater TF; England TJ; Callaghan P; Coates E; Sutherland KE; Eshtan SJ; Topcu G Health Technol Assess; 2019 Sep; 23(47):1-176. PubMed ID: 31524133 [TBL] [Abstract][Full Text] [Related]
12. Effects of Fluoxetine on Outcomes at 12 Months After Acute Stroke: Results From EFFECTS, a Randomized Controlled Trial. Lundström E; Isaksson E; Greilert Norin N; Näsman P; Wester P; Mårtensson B; Norrving B; Wallén H; Borg J; Hankey GJ; Hackett ML; Mead GE; Dennis MS; Sunnerhagen KS Stroke; 2021 Oct; 52(10):3082-3087. PubMed ID: 34465201 [TBL] [Abstract][Full Text] [Related]
13. Robot-assisted training compared with an enhanced upper limb therapy programme and with usual care for upper limb functional limitation after stroke: the RATULS three-group RCT. Rodgers H; Bosomworth H; Krebs HI; van Wijck F; Howel D; Wilson N; Finch T; Alvarado N; Ternent L; Fernandez-Garcia C; Aird L; Andole S; Cohen DL; Dawson J; Ford GA; Francis R; Hogg S; Hughes N; Price CI; Turner DL; Vale L; Wilkes S; Shaw L Health Technol Assess; 2020 Oct; 24(54):1-232. PubMed ID: 33140719 [TBL] [Abstract][Full Text] [Related]
14. An extended stroke rehabilitation service for people who have had a stroke: the EXTRAS RCT. Shaw L; Bhattarai N; Cant R; Drummond A; Ford GA; Forster A; Francis R; Hills K; Howel D; Laverty AM; McKevitt C; McMeekin P; Price C; Stamp E; Stevens E; Vale L; Rodgers H Health Technol Assess; 2020 May; 24(24):1-202. PubMed ID: 32468989 [TBL] [Abstract][Full Text] [Related]
15. A Very Early Rehabilitation Trial after stroke (AVERT): a Phase III, multicentre, randomised controlled trial. Langhorne P; Wu O; Rodgers H; Ashburn A; Bernhardt J Health Technol Assess; 2017 Sep; 21(54):1-120. PubMed ID: 28967376 [TBL] [Abstract][Full Text] [Related]
16. Supraglottic airway device versus tracheal intubation in the initial airway management of out-of-hospital cardiac arrest: the AIRWAYS-2 cluster RCT. Benger JR; Kirby K; Black S; Brett SJ; Clout M; Lazaroo MJ; Nolan JP; Reeves BC; Robinson M; Scott LJ; Smartt H; South A; Stokes EA; Taylor J; Thomas M; Voss S; Wordsworth S; Rogers CA Health Technol Assess; 2022 Apr; 26(21):1-158. PubMed ID: 35426781 [TBL] [Abstract][Full Text] [Related]
17. Sodium bicarbonate to improve physical function in patients over 60 years with advanced chronic kidney disease: the BiCARB RCT. Witham MD; Band M; Chong H; Donnan PT; Hampson G; Hu MK; Littleford R; Lamb E; Kalra PA; Kennedy G; McNamee P; Plews D; Rauchhaus P; Soiza RL; Sumukadas D; Warwick G; Avenell A Health Technol Assess; 2020 Jun; 24(27):1-90. PubMed ID: 32568065 [TBL] [Abstract][Full Text] [Related]
18. Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT. Kessler D; Burns A; Tallon D; Lewis G; MacNeill S; Round J; Hollingworth W; Chew-Graham C; Anderson I; Campbell J; Dickens C; Macleod U; Gilbody S; Davies S; Peters TJ; Wiles N Health Technol Assess; 2018 Nov; 22(63):1-136. PubMed ID: 30468145 [TBL] [Abstract][Full Text] [Related]
19. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs. Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602 [TBL] [Abstract][Full Text] [Related]
20. Exercise- and strategy-based physiotherapy-delivered intervention for preventing repeat falls in people with Parkinson's: the PDSAFE RCT. Ashburn A; Pickering R; McIntosh E; Hulbert S; Rochester L; Roberts HC; Nieuwboer A; Kunkel D; Goodwin VA; Lamb SE; Ballinger C; Seymour KC Health Technol Assess; 2019 Jul; 23(36):1-150. PubMed ID: 31339100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]